Navigation Links
Rare genetic disease offers insight into common cancers
Date:9/4/2012

Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing a variety of cancers, especially leukemias and head and neck cancer. Cruelly, the condition also nixes the use of an entire class of cancer drugs, namely drugs like mitomycin C that act by encouraging DNA to crosslink together like sticky strands of bread dough generally, healthy cells can repair a few crosslinks whereas cancer cells cannot and so are killed. However, Fanconi anemia patients are unable to repair the damage done to healthy or cancerous cells done by these drugs and so treatment with mitomycin C is frequently fatal.

A University of Colorado Cancer Center study funded by the Fanconi Anemia Research Fund explored the effectiveness of a novel agent in preventing cancer in this population namely, resveratrol as found in red wine. The results of this study will be presented at the 24th annual Fanconi Anemia Research Fund Scientific Symposium, September 27-30 at the Grand Hyatt Hotel in Denver, CO.

In fact, the findings may go far past Fanconi anemia.

"One of the Fanconi genes that is lost is BRCA2 the same genetic loss that causes many breast cancers," says Robert Sclafani, PhD, investigator at the University of Colorado Cancer Center and professor of biochemistry and molecular genetics at the CU School of Medicine. "So one mystery is why Fanconi anemia patients don't get breast cancer. In Fanconi, every cell in the body is missing that gene Fanconi is a very rare thing but it's telling us something about cancers that aren't so rare."

Sclafani's had already shown the effectiveness of resveratrol in treating head and neck cancer, and in this study explored the effect of resveratrol in Fanconi cell lines could it prevent cancer by eliminating the cancer cells in Fanconi patients?

"It turns out that regular Fanconi cells aren't sensitive to resveratrol in the way they're sensitive to drugs like mitomycin C," Sclafani says. Instead, Sclafani hopes that additional mutations found in Fanconi head and neck cancer cells will make them sensitive to resveratrol in a way normal Fanconi cells are not. His recent results will be presented at the upcoming meeting.

"It's an interesting population," says Sclafani "and one that may hold information about many kinds of cancer."


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Zülch Prize 2012 for founders of optogenetics
2. NIH-funded researchers restore sense of smell in mice using genetic technique
3. A new light shed on genetic regulations role in the predisposition to common diseases
4. Biophysicists unravel secrets of genetic switch
5. Early menopause: A genetic mouse model of human primary ovarian insufficiency
6. Vitamin B12 deficiency: Tracking the genetic causes
7. U of M researchers: Newly discovered genetic markers could signal colon cancer development
8. Ecologist: Genetically engineered algae for biofuel pose potential risks that should be studied
9. Scientists use light to tag and track genetic processes
10. New Genetics educational resource promotes active learning
11. Genetics Society of America’s GENETICS journal highlights for August 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... Bahama (PRWEB) , ... March 21, 2017 , ... Okyanos ... educational seminar as part of their live events series, “Stem Cell Therapy: The Next ... cell facility under the 2013 Stem Cell Research and Therapy Act, Okyanos ...
(Date:3/22/2017)... ... March 21, 2017 , ... Benchworks CEO ... Executive Officer Forum on March 23-24 in San Diego. The event is a ... diagnostic industries. , Benchworks Vice President Christian Meyer will also participate in the ...
(Date:3/22/2017)... ... , ... The Conference Forum has announced the launch of the 5th Annual ... 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit is the only ... and support. , “The Chief Medical Officer faces a unique set of challenges at ...
(Date:3/22/2017)... and CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... flow and tissue oxygenation, is being explored as a way to track the brain’s ... study on tonic pain activation by cold pressor test ,” published today in the ...
Breaking Biology Technology: